Literature DB >> 20161338

Synthesis of (R)-3,4-dihydro-2H-pyran-2-carboxaldehyde: application to the synthesis of potent adenosine A(2A) and A(3) receptor agonist.

Prakash G Jagtap1, Zhiyu Chen, Karsten Koppetsch, Elizabeth Piro, Paula Fronce, Garry J Southan, Karl-Norbert Klotz.   

Abstract

Synthesis of potent adenosine A(2A) and A(3) receptor agonist from the modification of adenosine-5'-N-ethylcarboxamide (NECA) has been reported. Diastereoisomer possessing an (R) 3,4-dihydro-2H-pyranyl (DHP) moiety exhibited the highest affinity at the A(2A) and A(3) receptors. The key steps involve the synthesis of (R)-3,4-dihydro-2H-pyran-2-carboxaldehyde (7), which was obtained through the enzyme catalyzed kinetic resolution of (±)-2-acetoxymethyl-3,4-dihydro-2H-pyran (5).

Entities:  

Year:  2009        PMID: 20161338      PMCID: PMC2679502          DOI: 10.1016/j.tetlet.2009.03.148

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  15 in total

Review 1.  A(3) adenosine receptor ligands: history and perspectives.

Authors:  P G Baraldi; B Cacciari; R Romagnoli; S Merighi; K Varani; P A Borea; G Spalluto
Journal:  Med Res Rev       Date:  2000-03       Impact factor: 12.944

Review 2.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 3.  Adenosine receptors: new opportunities for future drugs.

Authors:  S A Poulsen; R J Quinn
Journal:  Bioorg Med Chem       Date:  1998-06       Impact factor: 3.641

4.  The therapeutic potential of agents acting via purine receptors.

Authors:  J R Appleman; M D Erion
Journal:  Expert Opin Investig Drugs       Date:  1998-02       Impact factor: 6.206

Review 5.  Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.

Authors:  Rhalid Akkari; Joachim C Burbiel; Jörg Hockemeyer; Christa E Müller
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

6.  Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells.

Authors:  C A Salvatore; S L Tilley; A M Latour; D S Fletcher; B H Koller; M A Jacobson
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

7.  Parallel kinetic resolution of racemic aldehydes by use of asymmetric Horner-Wadsworth-Emmons reactions

Authors: 
Journal:  Org Lett       Date:  2000-02-24       Impact factor: 6.005

Review 8.  Medicinal chemistry of adenosine A2A receptor agonists.

Authors:  Gloria Cristalli; Catia Lambertucci; Sara Taffi; Sauro Vittori; Rosaria Volpini
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

9.  2-(N'-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators.

Authors:  K Niiya; R A Olsson; R D Thompson; S K Silvia; M Ueeda
Journal:  J Med Chem       Date:  1992-11-27       Impact factor: 7.446

Review 10.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

View more
  2 in total

1.  Activity-Directed Synthesis with Intermolecular Reactions: Development of a Fragment into a Range of Androgen Receptor Agonists.

Authors:  George Karageorgis; Mark Dow; Anthony Aimon; Stuart Warriner; Adam Nelson
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-11       Impact factor: 15.336

Review 2.  Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.

Authors:  Chrisna Matthee; Gisella Terre'Blanche; Lesetja J Legoabe; Helena D Janse van Rensburg
Journal:  Mol Divers       Date:  2021-06-27       Impact factor: 3.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.